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The ethanolic leaf extract of Hyptis suaveolens was evaluated for antimalarial activity against 
Plasmodium berghei in infected mice. In the 4 day suppressive test, 60 male and female albino mice (weight: 
18-23 g) were infected and treatment began immediatly (Day 0), while administration started 72 hours post 
infection in the curative test. For each test, mice were divided into 5 groups of 12 animals; each group was 
administered one of the following: 10 mg/kg, 25 mg/kg and 50 mg/kg of the crude extract, 5 mg/kg of 
chloroquine phosphate or 0.2 ml normal saline for four consecutive days. Thin blood smears were prepared nd 
examined microscopically under x 100 objective on day 4 to day 7 and the percentage parasitaemia were 
recorded. On day 7 the red blood cells (RBC), white blood cells (WBC), haemoglobin (Hb) and packed cell 
volume (PCV) were evaluated. The extract demonstrated dose-dependent inhibition effect on the parasites with 
42.76% and 18.03% at 50 mg/kg, 33.69% and 10.22% at 25 mg/kg for suppressive and curative tests 
respectively, while at 10 mg/kg, 22.39% and 6.06% suppression were recorded in the suppressive and curative 
tests respectively. The RBC, HB and PCV values decreased while there was an increase in WBC compared 
with that of the control. 
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Malaria is the world most important 
parasitic infection (Hay et al., 2004) and it 
remains a major impediment to health in 
Africa, south of the Sahara (Snow, 1999). It is 
reported to be a major cause of morbidity and 
mortality amongst Nigeria’s children 
population (Ayoola et al., 2005). It is 
estimated that 1-2 million people die yearly as 
a result of malaria (Sudhanshu et al., 2003). 
Efforts to reduce the high malaria 
morbidity and mortality rates have been 
hampered by the development to resistance, 
particularly by falciparum to long-standing 
conventional drugs such as chloroquine 
(Okoyeh et al., 1993, Ejov et al., 1999, 
Wongsrichanalai et al., 2002). This set back in 




drug control and eradication of malaria has 
necessitated the identification of new effective 
alternative drugs that are active against the 
resistant form of Plasmodium. 
Plants form the major part of treatments 
used by traditional healers in many societies. 
Thus, many plants have acquired reputation 
for being useful against malaria (Adesegun 
and Coker, 2001). It is estimated that 80% of 
the world population utilize traditional 
medicines for the treatment of diseases. The 
majority of African populations use traditional 
medicine for their health care needs. The 
medicaments are often bought in places such 
as open markets and local stores (WHO, 
2004). 
Ethno-medicines play a central role in 
the search for and development of new drugs 
(Kirby, 1997; Heinrich, 2000). Ajaiyeoba et 
al., (2003) in their ethno-graphic evaluation of 
ethno-medicine in Nigeria reported that many 
herbal remedies have been used traditionally 
for treatment of febrile illnesses in South-
Western Nigeria. In categorizing febrile 
illnesses, alongside their causes and 
symptoms, ordinary fever and rainy season 
fever are the two illnesses compactable with 
malaria infection. Studies have documented 
over 1,200 plant species from 160 families 
used in the treatment of malaria or fever 
(Willcox and Bodeker, 2004). Hermans et al. 
(2004) identified 85 species of plants used by 
the people in Benin who cannot resort to 
allopathic medicine to alleviate malaria 
symptoms. 30 species of plants belonging to 
28 genera in 20 families were commonly used 
in the preparation of the herbal remedies by 
the people of Dangme West District of Ghana, 
because they were more accessible and cost-
effective (Asase et al., 2010). Tabuti (2008) 
reported that out of the twenty-seven species 
of plants used for the treatment of malaria in 
Budiope county, Uganda, the most frequently 
mentioned were Vernonia amygdalina, 
Momordica foetida, Zanthoxylum chalybeum, 
Lantana camara and Mangifera indica. Bray 
et al. (2006) using crude extracts of 
Azadirachta indica, Cedrela odorata and 
Guarea multiflora of the meliaceae used 
traditionally as febrifuges together with 27 
limonoids extracted from malicious plants 
reported that none of the extracts tested 
showed high antiplasmodial activity and only 
far compounds were found to be moderately 
active. 
Studies have shown that some plants 
are highly toxic despite their high 
chemosuppression of parasitaemia. Morinda 
lucida which is top on the list of frequently 
used plants has shown i vitro cytotoxicity 
and the stem bark was reported to be 
extremely toxic (Ajaiyeoba et al., 2006). 
Idowu et al. (2010) in their search for 
published studies on the level of antimalarial 
activity and toxicity of the 38 plants in their 
study, reported that 80% have been 
documented to have antimalarial property but 
suppressive and none clearance, while about 
65% have toxic effects on the liver and kidney 
of experimental mice. 
Hyptis suaveolens is a strong-scented 
annual or perennial herb that reaches a height 
of 1.5 m found as weeds that are tropical and 
sub-tropical. With quadrate hairy stems and 
ovate to obovate leaves 3-5 cm long and 2-4 
cm wide, the margins serrulate with the lower 
surfaces densely hairy. Flowers are usually 
bisexual in small cymes along branch ends 
with reduced leaves. The calyx is inferior, 
persistent, bell-shaped and measures 5mm 
long in flowers, 10 mm long in fruit, corolla is 
blue and tubular nutlet about 1.2-1.5 mm long, 
slightly notched at the end (Stone, 1970). 
An infusion of the dried leaves of H. 
suaveolens is taken as a fever remedy. 
According to Dalziel (1955), it is tied round 
the head against headache or applied to cure 
boils. In some communities, the plant has 
been used in traditional medicine for the 
treatment of various illnesses such as stomach 
ache, diarrhea, dysentery and as eye remedy. 
The genus had been known to possess 23 
biologically active chemical compounds 
(Peerzada, 1997). Azevedo et al. (2001) 
identified a total of 40 compounds from oil 
samples obtained from Hyptis suaveolens in 




Brazil, accounting for 91-97% of the volatile 
constituents. However, there was a correlation 
between essential oil composition and 
geographic variations. Sesquiterpenes were 
mainly produced at lower altitudes where as 
monoterpenes at higher altitudes. Two 
triterpenoids obtained from the bark of Betula 
utilis and the root of H. suaveolens were 
reported to be similar to betulin and betulinic 
acid which have antitumor aactivity against 
human melanoma cell culture (Sharma et al., 
2010). Aqueous aerial parts of H. suaveolens 
extracts showed promising lymphocytes 
stimulating activities on non-specific cell-
mediated immune responses (Sriwanthana et 
al., 2007).              
Phytochemical investigation of the leaf, 
stem and root extracts of Hyptis suaveolens 
revealed the presence of flavonoids, steroids, 
terpenes, saponins, tannins, resins, glycosides. 
(Akueshi et al. 2002, Anyanwu and Dawet, 
2005, Egunyomi et al. 2010) with high 
amount in leaves, followed by stem and lower 
in root. The leaf extract was more toxic to 
mice than that of the stem which had an LD50 
2511.89 mg/kg and 3162.27 mg/kg 
respectively (Anyanwu and Dawet, 2005). 
Egunyomi et al. (2010) in a comparative study 
of the effectiveness of ethnobotanical 
mosquito repellents reported low repellency in 
H. suaveolens against Anopheles stephensi. H. 
suaveolens ethylacetate extracts was reported 
to significantly reduce probing activity of 
Aedes aegypti (L) (Jaenson et al., 2006). 
However, Attawish et al. (2005) in a 6 month 
study of the aqueous leaf extract of Hyptis 
suaveolens in wister rats reported that the 
plant did not produce any significant dose 
related changes of haematological 
parameters,serum biochemistry or 
histopathology of any internal organs. Studies 
on the insecticidal activity of the plant showed 
that it is a potential source of raw material for 
the control of Culex mosquito’s larvae and 
adults (Audu et al., 2002). Amusan et al. 
(2005) in a comparative toxicity study 
reported that the ethanolic extract of H. 
suaveolens showed low toxic effect on larvae 
of Ae .aegypti compared with the effect 
produced by Citrus sinensis oil extract. 
Similarly, Okigbo et al. (2010) reported that 
H. suaveolens showed little or no larvicidal 
activity against Culex mosquito larvae. 
Antimicrobial tests of the crude extracts 
showed that the plant has growth-inhibitory 
potential against microorganisms (Iwu et al., 
1990; Rojas et al., 1992; Akueshi et al., 2002). 
H. suaveolens did not exhibit antifungal 
activity against Aspergillus niger F2723 
(Babbarala et al., 2009). Shirwaikar et al., 
2003 reported the wound healing activity of 
the etanolic leaf extract of Hyptis suaveolens.  
Because of the devastating nature of malaria, 
there is an urgent need to develop new drugs 
or vaccines for the treatment, prevention and 
management of the disease. The present study 
was carried out to determine the in vivo 
antimalarial effect of Hyptis suaveolens 
against Plasmodium berghei in mice. 
 
MATERIALS AND METHODS 
Collection of experimental plant 
Hyptis suaveolens was obtained from 
Bwai in Mangu L.G.A, of Plateau State, 
Nigeria and identified by Prof. S.H.W. 
Hussaini, in the Department of Botany, 
University of Jos, Nigeria. A voucher 
specimen reference UJ/PGNS/HSP/1001 has 
been deposited at the Herbarium in the 
Department of Pharmacognosy, University of 
Jos, Nigeria. The leaves were collected and 
dried in the open air under shade and 
pulverized using mortar and pestle. 
 
Extraction of the plant material 
This was carried out as described by 
Anyanwu and dawet (2005). Sixty (60) grams 
of the powdered leaf was extracted with the 
aid of a soxhlet extractor using 350 ml of 99% 
ethanol for 72 hours. The extract was 
concentrated to dryness using a rotary 
evaporator and the residue stored in the 
freezer at 4 ˚C. Prior to use, the extract was 
dissolved in normal saline so that the doses 




required was prepared by necessary dilutions 
and given according to weight of the animal. 
 
Drug 
Chloroquine phosphate (Drug field, 
Nigeria) was diluted in normal saline to final 
doses of 5 mg/kg body weight. 
 
Animals 
Ethical approval was obtained from the 
ethical committee of the Animal House, 
University of Jos, Jos, Nigeria. Animals were 
treated as approved by international standard 
for the treatment of experimental animals. 
Healthy male and female albino mice, 
weighing 18-23 g were obtained from the 
Nigerian Institute for Trypanosomiaesis 
Research (NITR), Vom near Jos, and were 
kept in the animal house of the University of 
Jos in cages (25cm × 20cm × 10cm) with 
perforated metal cover for free passage of air, 
under approximately 12 hours periodicity of 
light / dark cycle. The animals were left to 
acclimatize for two weeks prior to their use 
for the experiment. They were fed on standard 
pellet diet with water ad libitum. 
 
Parasite 
Chloroquine sensitive Plasmodium 
berghei were obtained from the National 
Institute for Pharmaceutical Research and 
Development (NIPRD), Abuja, Nigeria. The 
parasites were maintained by intraperitoneal 
inoculation of mice with diluted blood 
obtained by cutting the tip of the tail of 
Plasmodium berghei infected mice. 
 
Parasite inoculum 
The inoculum consisted of 1.2 × 107 
Plasmodium berghei parasitized red blood 
cells per millilitres. This was done by 
determining both the percentage of 
parasitaemia and the red blood cells count of 
the donor mice using an improved neubear 





Chloroquine phosphate was adminis- 
tered intraperitoneally using syringe and 
needle while the extract was orally 
administered using a feeding cannula. 
 
Antimalarial activity 
4-day suppressive test  
The suppressive test was conducted in a 
similar method followed by Mesia et al. 
(2005) and Iwalokun (2008). 60 animals were 
divided into 5 groups of 12 animals each. 
Three of the 5 groups was each administered 
one of the following: 50 mg/kg, 25 mg/kg or 
10 mg/kg of the extract. A group was 
administered chloroquine phosphate (5 
mg/kg) as positive control, while the other 
group (negative control) received 0.2 ml 
normal saline. Each mouse was inoculated on 
the first day (Do), intraperitoneally, with 
infected blood containing Plasmodium 
berghei parasitized red blood cells. The mice 
were treated daily from day 0 (immediately 
after infection) to day 3. Thin smears fixed in 
methanol stained with Giemsa stain were 
prepared from the tail blood of each mouse 
daily from day 4 to day 7, examined 
microscopically under oil immersion and the 
percentage parasitaemia was determined by 
counting the parasitized erythrocytes out of 
200 erythrocytes in random fields. The mean 
parasite count for each group was determined 
and the average percentage chemosuppression 
for each dose was calculated as [(A-B)/A], 
where A is the average percentage of 
parasitaemia in the negative control (normal 
saline group) and B is the average percentage 
of parasitaimia in the test groups. 
 
Rane (curative) test 
 This was conducted in a similar 
method adopted by Tona et al. (2001) and 
Iwalokun (2008). Another set of 60 albino 
mice were infected with parasitized 
erythrocytes. Seventy-two hours after 
infection, the mice were divided into 5 groups 
of 12 animals. Three of the 5 groups was each 
administered one of the following: 50 mg/kg, 




25 mg/kg or 10 mg/kg of the leaf extract. The 
fourth group was given 5 mg/kg of 
chloroquine phosphate while the last group 
(negative control) received 0.2 ml normal 
saline. Each mouse was treated orally once 
daily with the dose for 4 consecutive days 
(D4-D7) post inoculation during which the 
parasitaemia level was monitored daily. 
 
Haematological parameters 
On day 7, blood was obtained from the 
experimental mice by cutting the tip of the tail 
and collected in heparinised tubes. Blood 
parameters were determined using the method 
of Dacie and Lewis as described by Ibu and 
Adeniyi (1989). White blood cell (WBC) and 
Red blood cell (RBC) were determined using 
haemocytometer. The haemoglobin (Hb) 
concentration was measured with C210 digital 
calorimeter in optical density (Å) with 
drabkins solution as reference for zero 
adjustment. The packed cell volume (PCV) 
was determined using microhaematocrit. 
 
Statistical analysis 
Student’s t-test was used to compare 
the treated groups and the untreated groups, 





The changes in the parasitaemia in 
mice administered Hyptis suaveolens leaf 
extract is shown in Table 1. The groups 
treated with 50 mg/kg, 25 mg/kg and 10 
mg/kg leaf extract, chloroquine phosphate and 
normal saline had percentage parasitaemia of 
24.42±1.38, 28.67±1.2, 33.3±1.52, 21.17±0.94 
and 37.87±1.36 respectively. The percentage 
parasitaemia in groups administered the doses 
of the leaf extract and normal saline increased 
throughout the period of observation, while a 
decrease was observed in the positive control 
group administered the chloroquine 
phosphate.  The percentage parasitaemia was 
higher in the control group followed by 10 
mg/kg, 25 mg/kg, 50 mg/kg leaf extract and 5 
mg/kg chloroquine phosphate with 67±2.8, 
53.17±2.08, 49.36±2.34, 47.25±1.41 and 
0.56±0.15 respectively on day 7. However, 
even though the mean parasitaemia in mice 
given the ethanolic leaf extract decrease, it 
was significantly (P<0.05) lower than that in 
the negative control (normal saline group) 
only in the 50 mg/kg group. 
 
 Curative test 
In this study the mean percentage 
parasitaemia on day 4 was 27.67±1.34, 
31.58±1.92, 32.20±1.45, 19.25±1.02 and 
32±2.08 for 50 mg/kg, 25 mg/kg, 10 mg/kg 
leaf extract, 5 mg/kg chloroquine phosphate 
and normal saline respectively (Table 2). The 
percentage parasitaemia gradually increased 
in groups treated with the doses of the leaf 
extract and normal saline with 52.25±2.1, 
59.74±2.06, 61.92±2.91 and 68.92±4.66 in the 
50 mg/kg, 25 mg/kg, 10 mg/kg leaf extract 
and normal saline groups respectively. While 
there was a decrease in parastiaemia in the 
groups administered chloroquine phosphate 
from 19.25±1.02 on day 4 to 0.65±0.21 on day 
7. The decrease in percentage parasitaemia in 
groups administered leaf extract 72 hours post 
infection was not significant (P>0.05) 
compared with the  normal saline groups. 
The mean percentage parasitaemia 
through out the period of observation was 
high at 10 mg/kg dose with 42.6±4.35 and 
47.41±6.49 for the 4-day suppressive and 
curative test respectively. (Table 3). As the 
dose increased, the mean parasitaemia 
decreased, which at 50 mg/kg was 31.42±3.44 
and 41.37±5.27 in the suppressive and 
curative test respectively. The mean 
parasitaemia in the normal saline (negative 
control) rose to 54.89±6.48 and 50.47±8.11 in 
the suppressive and curative groups 
respectively, while that of the positive control 
group (chloroquine Phosphate) fell to 
8.97±4.89 and 8.09±4.4 in suppressive and 
curative tests respectively. 
Hyptis suaveolens extract produced a 
dose-dependent effect at the doses employed 
in this study. At 50 mg/kg dose the 
chemosuppression was 42.76% and 18.03% in 




suppressive and curative test respectively 
while 10 mg/kg dose produced the least 
chemosuppression of 22.39% and 6.06% in 
suppressive and curative tests respectively 
amongst the extract treated groups as against 
83.66% and 83.97% suppression induced by 
the standard drug chloroquine phosphate in 
suppressive and curative test respectively. In 
observing the relationship between the treated 
and untreated groups, students t-test showed 
that the decreased in parasitaemia in extract 
treated groups were not significant (P>0.05), 
while the standard drug chloroquine 
phosphate significantly (P<0.01) reduced the 
level of parasitaemia compared with that of 
the normal saline (negative control) group. 
 
Haematological parameters 
In the suppressive test, infection of 
mice with Plasmodium berghei reduced RBC 
from 5.47±0.29 to 3.62±0.81 in the 
chloroquine phosphate and normal saline 
group respectively (Table 4). The WBC rose 
from 5.46±0.81 in chloroquine phosphate 
treated (positive control) groups to 7.52±1.03 
in the normal saline (negative control) group. 
The haemoglobin levels fell from 17.81±1.07 
to 12.43±0.74 in chloroquine phosphate and 
normal saline groups respectively. The PCV 
level was reduced from 49±1.53 to 
40.53±1.84 in chloroquine phosphate and 
normal saline groups respectively. However, 
haemoglobin parameters in the groups 
administered the extracts showed a dose 
depended effect. Similarly, the curative test 
showed that the presence of Plasmodium 
berghei reduced the RBC, Hb and PCV of 
mice while it increased the WBC (Table 5). 
The ethanolic leaf extract showed a dose 
dependent effect on the haemological 
parameters in the Plasmodium berghei 
infected mice with more reduction in the 
RBC, Hb and PCV in groups given 10 mg/kg 
followed by groups that received 25 mg/kg 
and 50 mg/kg. High WBC was recorded in 
groups that receive 10 mg/kg than 25 mg/kg 
and 50 mg/kg with 6.74±0.55, 6.42±0.81 and 
6.02±0.16 respectively against 5.75±0.14 and 
7.03±1.21 in the chloroquine phosphate and 
normal saline respectively. However, the 
changes in these haematological parameters 
were not statistically significant (P>0.05).
 
Table 1: Changes in parasitaemia in mice infected with Plasmodium berghei on day 0, following 
daily treatment on day 0-3 with ethanolic leaf extrac s of Hyptis suaveolens.       
 
Day 50 mg/kg 25 mg/kg 10 mg/kg CQ 5 mg/kg Normal saline 
4 24.42±1.38 28.67±1.20 33.30±1.52 21.17±0.94 37.87±1.36 
5 26.58±1.35 30.50±1.14 38.25±1.50 12.58±1.09 52.58±3.33 
6 37.42±1.20 37.08±1.92 45.67±1.50 1.58±0.15 62.32±2.03 
7 47.25±1.41 49.36±2.34 53.17±2.08 0.56±0.15 67.00±2.80 
CQ=Chloroquine phosphate 
Data are mean ± standard error for twelve nice per group. 
 
 
Table 2: Changes in parasitaemia in mice infected with Plasmodium berghei on day 0, treated daily 
on day 3-6 with ethanolic leaf extract of Hyptis suaveolens. 
 
Day 50 mg/kg 25 mg/kg 10 mg/kg    CQ 5 mg/kg Normal saline 
4 27.69±1.34 31.58±1.92 32.20±1.45    19.25±1.02 32.00±2.08 
5 29.35±1.53 40.00±1.50 42.07±1.74    11.25±0.98 43.10±1.81 
6 46.20±1.21 49.92±1.07 53.40±2.04      1.22±0.51 57.83±2.52 
7 52.25±2.10 59.74±2.06 61.92±2.91      0.65±0.21 68.92±4.66 
 
CQ= Chloroquine phosphate 
Data are mean ± standard error for twelve nice per group.  




Table 3: In vivo anti-malarial activity of ethanolic leaf extract of Hyptis suaveolens and 
Chloroquine phosphate in mice infected with Plasmodium berghei. 
 








Leaf 50 31.42±3.44* 42.76 
Leaf 25 36.40±4.68* 33.69 
Leaf 10 42.60±4.35* 22.39 
Chloroquine Phosphate 5 8.97±4.89** 83.66 
Normal saline 0.2 ml 54.89±6.48 - 
Rane 
(Curative) 
Leaf 50 41.37±5.27 18.03 
Leaf 25 45.31±6.10 10.22 
Leaf 10 47.41±6.49 6.06 
Chloroquine Phosphate 5 8.09±4.40 83.97 
 Normal saline 0.2 ml 50.47±8.11 - 
  S.E. = Standard Error. 
  *significant at p<0.05 compared with the normal saline (control). 
  **significant at p<0.01 compared with the normal s ine (control). 
 
 
Table 4: Haematological level of mice infected with Plasmodium berghei in the 4-day suppressive 




RBC x 106 /mm3 WBC x 103 
/mm3 
Hb (g/dl) PCV (%) 
50 Ext. 4.64±0.32 5.84±0.24 15.33±0.85 44.00±2.63 
25 Ext. 4.01±0.57 6.01±0.28 14.09±0.67 42.09±2.21 
10 Ext. 3.91±0.21 6.51±0.52 14.50±1.02 1.90±0.74 
5   CQ 5.47±0.29 5.46±0.81 17.81±1.07 49.00±1.53 
0.2 ml Ns 3.62±0.81 7.52±1.03 12.43±0.74 40.53±1.84 
RBC=Red blood cell; WBC= White blood cell; Hb= Haemoglobin; PCV= Packed cell volume. 
Ext = Extract; CQ = Chloroquine phosphate; Ns = Normal saline. 
Data are mean ± standard error for twelve mice per group. 
 
 
Table 5: Haematological levels of mice infected with Plasmodium berghei in the Rane (curative) 




RBC x 106 /mm3 WBC x 103 
/mm3 
Hb (g/dl) PCV (%) 
50 Ext. 4.23±0.76 6.02±0.16 14.60±0.81 43.13±1.11 
25 Ext. 3.70±0.15 6.42±0.81 13.82±1.32 41.00±8.04 
10 Ext. 3.48±0.21 6.74±0.55 13.05±0.73 40.05±0.05 
5   CQ 5.27±0.85 5.75±0.14 17.40±1.04 47.00±4.36 
0.2 ml Ns 3.12±0.49 7.03±1.21 12.84±0.42 39.02±0.53 
RBC= Red blood cell; WBC= White blood cell; Hb=Haemglobin; PCV= Packed cell volume  
Ext = Extract; CQ = Chloroquine phosphate; Ns = Normal saline. 
Data are mean ± standard error for twelve mice per group. 
 
 





The extract showed dose-dependent 
effects, with the higher doses resulting in 
greater reduction in the parasite load than the 
lower doses which gave 22.39% and 6.06% at 
10 mg/kg for suppression and curative tests 
respectively. The dose effect observed in this 
study is in accord with the finding of Awe and 
Makinde (1998), Tona et al. (2001) and 
Iwalokun (2008), who separately reported 
greater reduction in the parasitaemia at higher 
doses than lower. The reduction in the 
percentage parasitaemia was more in the 
suppressive test than the curative test. This 
observation was supported by the 
haematological test which showed slight 
reduction in the RBC, Hb and PCV and 
increase in WBC at higher doses than lower 
compared with the normal saline group. The 
reduction in RBC, Hb and PCV and the 
increase in WBC of infected mice was more 
observed in the curative than suppressive 
tests. This is consistent with work of Okochi 
et al. (1999) who reported increase in WBC 
and decrease in RBC, Hb and PCV in rats 
infected with Trypanosama bracei. 
The result of this study showed that the 
ethanolic leaf extract of Hyptis suaveolens 
may not have a therapeutic effect; however, it 
could probably be a potential prophylactic 
agent. The reduction in parasitaemia of the 
groups treated with the extract compared with 
the normal saline (negative control) group 
could probably be due to the bioactive 
composition of the plant. Mesia et al. (2005) 
attributed the antimalarial activities of Croton 
mubango to the presence of alkaloids and 
terpenoids detected in the plant extracts. Tona 
et al. (2001) reported that Cassia occidentalis, 
Morinda morindoides and Phyllanthus niruri 
significantly reduced parasitaemia in 
Plasmodium berghei infected mice. 
A study conducted by Bala et al. (2006) 
showed that Aloe vera and Coriandrum 
sativum were not generally effective in 
eliminating Trypanosoma brucei brucei 
infection in albino rats. Iwalokun (2008) 
reported that Vernonia amygdalina, aqueous 
leaf extract has the inherent ability to work in 
favour of the restoration of chloroquine 
efficacy as a prophylactic and 
chemotherapeutic agent against chloroquine 
sensitive and resistant Plasmodium berghei 
infection in mice. Nwabuisi (2002) reported 
the prophylactic effect of multi-herbal 
preparation “Agbo-Iba” against Plasmodium 
yoelii nigeriensis in mice and reported no 
significant side effects. 
The result of this study indicates that 
Hyptis suaveolens ethanolic leaf extract have 
antimalarial potentials. The plant extracts 
should be extensively investigated to isolate 
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